Orgovyx Tablet, Film Coated
Product Images NDC 72974-120
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Orgovyx (NDC 72974-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sumitomo Pharma America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Orgovyx 02)
Figure 2 (Orgovyx 03)
Figure 3 (Orgovyx 04)
Figure 3 (Orgovyx 05)
The text represents a chart or graph showing the cumulative incidence of time for testosterone to be less than 20 ng/dL for two different treatments, Regulix and Leuprolide, over a period of weeks. The number of patients at risk for each week is also shown. Therefore, the chart is useful for analyzing the effectiveness of these treatments in reducing testosterone levels.*
Principal Display Panel (120 mg Tablet Bottle Label)
This is a medication called ORGOVYX, which comes in tablet form with a recommended dosage that can be found in the prescribing information. It should be kept out of reach of children and stored at room temperature, but not above 30°C. The medication is distributed by Myovant Sciences and manufactured by Bushu Pharmaceuticals in Japan, but is a product of Germany. The medication is available in a package of 30 tablets, with each tablet containing 120 mg of relugolix. The NDC number for this product is 72974-120-01 and it is only available with a prescription (Rxonly).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.